Try the modernized ClinicalTrials.gov beta website. Learn more about the modernization effort.
Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT03161353
Brief Title: Chemotherapy-free Trastuzumab and Pertuzumab in HER2-positive Breast Cancer: FDG-PET Response-adapted Strategy. (PHERGain)

First Submitted : May 15, 2017
First Submitted that Met QC Criteria : May 18, 2017
First Posted : May 19, 2017

Last Update Submitted that Met QC Criteria : March 3, 2021
Last Update Posted : March 4, 2021